The FMCG firm reported a 1% drop in net profit to Rs 209.86 crore for Q2 FY26, even as revenue rose 1.32% year-on-year to Rs 1,150.17 crore amid a dynamic market environment
The healthcare arm of Procter & Gamble reports steady second-quarter growth driven by brand strength, new product launches, and supply chain gains
Here is the complete list of stocks that will remain in focus today as they trade ex-dividend on August 28, along with their respective dividend announcements and record dates
The company's revenue from operations was largely flat at ₹937 crore in the quarter ended June. Its advertising expenses were down 55.3 per cent in the at ₹69 crore
Procter & Gamble Hygiene and Health Care Ltd on Wednesday reported an over two-fold jump in its profit after tax to Rs 192.06 crore in the fourth quarter ended June 2025. The company, which follows the July-June financial year, had reported a profit after tax of Rs 81.06 crore in the corresponding quarter of the previous fiscal. Revenue from operations of Procter & Gamble Hygiene and Health Care Ltd (PGHH) was marginally up by 0.56 per cent to Rs 937.03 crore in the June quarter. The same stood at Rs 931.75 crore in the corresponding period a year ago. The company's PAT was "significantly up due to the impact of higher advertising investment in the base period," according to the earnings statement from PGHH, which operates in the healthcare and feminine care segment with brands Vicks and Whisper in its portfolio. PGHH's total expenses declined 17.75 per cent to Rs 680.02 crore in the June quarter. Its total income, which includes other income, grew marginally to Rs 944.72 ...
Currently chief operating officer, Jejurikar will succeed Jon Moeller as chief executive officer and become the first Indian to lead Procter & Gamble in its history